Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
Zbar
A P
AP
Academic Department of Colorectal Surgery, Hammersmith Hospital, London, UK.
Lemoine
N R
NR
Wadhwa
M
M
Thomas
H
H
Snary
D
D
Kmiot
W A
WA
D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000276:immunology; D000918:Antibody Specificity; D000951:Antigens, Neoplasm / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000276:immunology*; D002277:Carcinoma / Q000276:immunology / Q000628:therapy*; D015179:Colorectal Neoplasms / Q000276:immunology / Q000628:therapy*; D005544:Forecasting; D006801:Humans; D007111:Immunity, Cellular; D007157:Immunologic Surveillance; D007167:Immunotherapy; D016233:Immunotherapy, Active; D014614:Vaccines, Synthetic / Q000627:therapeutic use
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001324:Autoantigens; D019496:Cancer Vaccines; D002272:Carcinoembryonic Antigen; D014614:Vaccines, Synthetic